Molecular analysis of thymopentin binding to HLA-DR molecules

Area of Science:

• Immunology
• Molecular Biology
• Structural Biology

Background:

• Thymopentin (TP5) is known to trigger immune responses, but its precise molecular mechanism remains unclear.
• Immunomodulation by TP5 is hypothesized to involve complex formation with human leukocyte antigen DR (HLA-DR) molecules before T cell interaction.

Purpose of the Study:

• To investigate the molecular basis of Thymopentin (TP5) interaction with human leukocyte antigen DR (HLA-DR).
• To confirm the direct binding and complex formation between TP5 and HLA-DR in antigen-presenting cells (APCs).

Main Methods:

• Utilized fluorescent-labeled TP5 to observe uptake and binding to HLA-DR on EBV-transformed B cells.
• Employed inhibition assays with unlabeled TP5 to confirm binding specificity.
• Applied molecular modeling strategies, including alanine substitutions and HLA-DR mutants, to predict complex formation.

Main Results:

• Demonstrated direct binding of TP5 to HLA-DR molecules on APCs.
• Confirmed specific recognition and binding of TP5 by HLA-DR.
• Molecular modeling revealed distinct conformations of TP5 upon binding to HLA-DR and identified key residues (Glu11, Asn62) and the Val anchor's role.

Conclusions:

• TP5 associates with HLA-DR in living APCs, providing a mechanism for its immunomodulatory effects.
• The findings offer a novel strategy for understanding TP5's immunomodulation and designing new immunoregulatory polypeptides.